Efficacy and tolerability of aclidinium bromide/formoterol fumarate fixed-dose combination in patients with COPD: A 1-year study

CONCLUSIONS: Sustained improvements in lung function were observed in patients with COPD treated with a fixed-dose combination of aclidinium/formoterol for 1 year compared with formoterol. FDC tolerability was comparable to formoterol alone.

Source: European Respiratory Journal - December 23, 2014 Category: Respiratory Medicine Authors: Make, B., Donohue, J., Soong, W., Zhong, X., Leselbaum, A., Caracta, C. Tags: 5.1 Airway Pharmacology and Treatment Source Type: research